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Abstract. Ocular anomalies may occur in craniofacial microsomia (CFM). The aim of
this systematic review was to review the literature on ocular anomalies and their
incidence, in order to estimate the need for ophthalmological screening in CFM
patients. Online databases were searched, and data on the number of patients, type
and incidence of ocular anomalies, and visual acuity were extracted. Four subgroups
of ocular and adnexal anomalies were identified, to provide an overview of the
different anomalies. Twenty-five papers analysing 1419 patients in total were
included. Ocular anomalies were documented in 6.7–100% of patients. The most
reported type I ocular anomalies were eyelid coloboma, lipodermoids, and orbital
dystopia. The most reported type II ocular anomalies were epibulbar dermoid,
microphthalmia, and anophthalmia. Ptosis and strabismus were the most reported
type III anomalies, and irregular astigmatism was the most reported type IV ocular
anomaly. Visual impairment in general was reported in 8–71.4% of patients, with
severe visual impairment in 11.1–71.4% and amblyopia in 16.3%. This study
provides a detailed overview of ocular anomalies in CFM and their prevalence.
Furthermore, we propose a new classification to organize ocular anomalies into four
clinically relevant subtypes. Finally, the high prevalence of ocular anomalies and
visual impairment in this study suggests that CFM patients should undergo
ophthalmological screening at least once during the sensitive period.Please cite this article in press as: Rooijers W, et al. Ocular and adnexal anomalies in craniof
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Accepted for publication 3 March 2020Craniofacial microsomia (CFM) is a rare
congenital disorder affecting structures
derived from the first and second branchial
arches. With an incidence of 1:3000 to
1:20,000 live-births, it is the second most
common congenital craniofacial disorder
after cleft lip and palate1–5. The disorder ischaracterized by underdevelopment of the
orbit, mandible, ear, facial nerve, and soft
tissues. Furthermore, several extracranio-
facial malformations, i.e. cardiac, renal,
vertebral, and central nervous system
anomalies, are associated with CFM6,7.
In addition to anatomical anomalies, func-tional anomalies, such as feeding difficul-
ties and obstructive sleep apnoea, have
also been associated with CFM8–11.
CFM is known by several synonyms,
including the first and second branchial
arch syndrome, hemifacial microsomia,
and lateral facial dysplasia. Goldenharacial microsomia: a systematic review, Int
ssociation of Oral and Maxillofacial Surgeons. All
rights reserved.
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Fig. 1. PRISMA diagram of the record selection process.described CFM patients with ocular der-
moids and extracraniofacial anomalies as
a subtype of CFM, known as Goldenhar–
Gorlin syndrome, Goldenhar syndrome
(GS), or oculo-auriculo-vertebral spec-
trum (OAVS)12–14. However, Vento
et al. refuted GS/OAVS as a subtype of
CFM, as they found no association be-
tween these anomalies15. Tuin et al. con-
cluded that use of the term GS is
inconsequential, as not all GS patients
meet the diagnostic criteria16. Also, Caron
et al. recently concluded that there are no
phenotypically distinct groups in the CFM
spectrum17. In this paper we will therefore
use CFM to refer to all earlier synonyms
and GS/OAVS.
Several ocular and adnexal anomalies
have been described in CFM. These anom-
alies include epibulbar dermoids, lipoder-
moids, eyelid coloboma, microphthalmia,
anophthalmia, and anomalies of the
lacrimal caruncle. Furthermore, visual im-
pairment, strabismus, and Duane syn-
drome have been described in CFM.
The aim of this study was to document
the different types and incidence rates of
ocular anomalies in order to recognize and
treat these as early as possible and thereby
prevent or limit the lasting consequences
of the anomalies.
Methods
Search strategy
A systematic search of the literature was
conducted to identify papers on CFM (or
its synonyms) and ocular or adnexal
anomalies. The search was conducted in
the PubMed, Embase, MEDLINE, Ovid,
Cochrane, Web of Science, and Google
Scholar databases. The databases were
searched from inception until March
2016. The full search string used in the
databases is included in Appendix A (Sup-
plementary Material). For clarification,
known synonyms of CFM that were used
in the search are included in Appendix B
(Supplementary Material). In addition, a
manual search was performed to identify
secondary sources in the references of the
articles initially identified. No date limit
was applied, but the results were limited to
human subjects and papers written in En-
glish. Case reports, conference abstracts,
letters, notes, and editorials were exclud-
ed.
Two investigators (W.R. and C.J.J.M.
C) independently selected the studies.
Titles and abstracts were screened for
relevance and selected based on the inclu-
sion and exclusion criteria. Inclusion cri-
teria were (1) CFM or one of its synonyms,Please cite this article in press as: Rooijers W
J Oral Maxillofac Surg (2020), https://doi.oand (2) ocular or adnexal anomalies. Only
original studies were included. Articles for
which the titles and abstracts were missing
sufficient information to determine eligi-
bility according to the inclusion and ex-
clusion criteria underwent a full-text
review.
Data extraction
Prior to data extraction, a table was estab-
lished with the study characteristics to be
assessed during the full text review. This
included data on the type of study, number
of patients included, number of affected
patients, availability of vision tests, and
number of ocular anomalies per patient.
Specific ocular anomalies were noted sep-
arately in this table. All studies were grad-
ed on quality of evidence using the Oxford
Centre for Evidence-Based Medicine cri-
teria.
Classification of ocular anomalies
Ocular anomalies were categorized into
four different categories. Type I ocular, et al. Ocular and adnexal anomalies in craniof
rg/10.1016/j.ijom.2020.03.003anomalies were defined as anatomical oc-
ular or adnexal anomalies that in general
do not tend to impair vision. Type II ocular
anomalies were defined as anatomical oc-
ular or adnexal anomalies that impair, or
are likely to impair vision. Motility dis-
orders of the eye or adnexa were defined as
type III ocular anomalies. Refractive
errors were separately categorized as type
IV ocular anomalies. There is no ranked
order indicating a more or a less severe
anomaly in these categories.
Results
A total of 4900 papers were identified in
the initial search, of which 2754 were
screened after the duplicates had been
removed. Of these, 2713 records were
excluded after screening the title and ab-
stract for relevance. Forty-one full-text
records were screened for eligibility. In
total, 25 records were included for quali-
tative analysis. A PRISMA diagram of the
record selection process is presented in
Fig. 1.acial microsomia: a systematic review, Int
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Of the 25 records included, 14 were retro-
spective studies15,16,18–29, one was a pro-
spective study30, and 10 were case
series31–40. The prospective study also
had a retrospective component, in which
patient charts were reviewed for additional
information. Patients with isolated micro-
tia were included in four studies; where
possible, these patients were excluded
from further analysis. A total of 1432
patients were analysed in this literature
review, but it should be noted that 13
patients were analysed twice, once by
Baum and Feingold31 and once by Fein-
gold and Baum34, bringing the total to
1419 patients in 25 records. The number
of patients per record varied from 6 to 294
patients. The characteristics of the includ-
ed studies are reported in Table 1.
Documented type I ocular anomalies
Type I ocular anomalies were described
in 22 records15,16,18–28,30–34,36,37,39,40.
The most described anomaly was
eyelid coloboma in 13 records, with inci-
dences ranging between 3.9% and
40%18,19,21,23,24,26,27,31,32,34,37,39,40. Orbit-
al dystopia was described in seven
records, with incidences ranging between
3.9% and 43%15,16,19,20,25,26,32. Lipoder-
moids were described in six records, with
incidences ranging from 4.1% to
75%22,26,30,31,33,34. Anomalies of the lac-
rimal organ, e.g. dacryostenosis, tear duct
hypoplasia, and/or tear duct obstruction
were described in seven records, with
incidences ranging from 4.8% to
14.3%21,22,24,26,31,33,40. An iris coloboma
was described in five records, in 1.5–30%
of patients18,21,26,31,36.
Three records described dystopia
canthorum as a separate entity, with
incidences ranging from 3.9% to
45.8%19,22,28. Telecanthus was described
in two records, with an incidence of
2–4.8%22,33. Epicanthus and antimongo-
loid slanting of the eyelids were both
described in three records, with incidences
ranging between 5.4% and 5.9% and be-
tween 14.3% and 15.4%, respective-
ly18,19,26,31,36. Three records described
caruncle anomalies (incidence 1.8–
14.3%)24,31,36, one described eyelid tags
(7.7%) and eyebrow coloboma (7.7%)31,
and one record described eyelid retraction
in 2% of patients22.
Tortuous retinal vessels (1.8–14.3%)
were described in three records22,24,36.
Mansour et al. also described fundus
hypopigmentation in one of 57 patients24.
Baum and Feingold separately describedPlease cite this article in press as: Rooijers W
J Oral Maxillofac Surg (2020), https://doi.ocanthus coloboma in 23.1% of patients31,
and Hertle et al. described entropion in
4.1% of patients22. An overview of the
type I ocular anomalies is presented in
Table 2.
Documented type II ocular anomalies
Type II ocular anomalies were described
in 21 records15,16,18–21,23–27,30–37,39,40.
Epibulbar dermoids were the most often
described, reported in 15 records, with
incidences ranging from 6.7% to
100%15,16,18,19,21,24,26,30–34,37,39,40. Tasse
et al. described a 20.4% incidence of
ocular dermoids, not differentiating be-
tween epibulbar dermoids and lipoder-
moids27. Microphthalmia was described
in 14 records, with incidences ranging
from 1.8% to 57.1%15,16,18–20,24–
26,30,31,33,36,37,40. Anophthalmia was de-
scribed in six records, with incidences
ranging between 1.5% and
42.9%18,21,23,27,36,37. Cryptophthalmos
was described by Baum and Feingold in
7.7% of patients31.
Exposure keratitis and cornea ulcer
were described in 30% and 7.7%, respec-
tively31,39. Baum and Feingold also de-
scribed a microcornea in 15.4% of
patients31. An opacity of the lens was
described in two records, but only
Ewart-Toland et al. reported the inci-
dence, at 4.8%26,33. Barisic et al. described
a complete absence of the lens in one of
the 259 patients included18.
Four records described optic nerve
anomalies in 4.8–14.3% of patients, with
Ewart-Toland et al. specifically describing
optic nerve hypoplasia in 4.8% of
patients26,33,35,36. Two records reported a
fundus coloboma in 1.8% and 7.7% of
patients, respectively24,31. An overview
of the type II ocular anomalies is presented
in Table 3.
Documented type III ocular anomalies
Type III ocular anomalies were described
in 13 records21–24,26–28,31,34–36,39,40. Ptosis
was most frequently described (in six
records), with an incidence of 8.3–
14.3%22,24,26,28,36,39. Furthermore, Man-
ara et al. and Margolis et al. described
anomalies of the abducens nerve in 27.6%
and 28.6% of patients, respectively35,36.
Manara et al. also described anomalies of
the oculomotor, trigeminal, facial, and
vestibulo-cochlear nerve in 3.4%,
37.9%, 37.9%, and 27.6%, respectively35.
Anomalies concerning the motility of
the eye were frequently described, but not
always specified. Four records described, et al. Ocular and adnexal anomalies in craniof
rg/10.1016/j.ijom.2020.03.003extraocular muscle anomalies (not speci-
fied) in 19–38.5% of patients24,31,34,39.
Strabismus (cause not specified) was
described in five records, with an inci-
dence of 7.7–22%21,22,26,27,40. Five
records specified the type of strabismus:
Duane syndrome (1.8–15.4%), esotropia
(4.1–15.4%), and exotropia (5.3–7.7%)
were reported22,24,26,31,36. Hertle et al.
and Jacobsson and Granstro¨m also de-
scribed abducens nerve palsy separately
in 4.1% and 26.9% of patients, respective-
ly22,23. Furthermore, Hertle et al. de-
scribed superior oblique muscle palsy,
strabismus sursoadductorius, and mono-
fixation syndrome as specific eye motility
disorders22. Finally, Baum and Feingold
described hypertropia in one out of 13
patients31. An overview of the type III
ocular anomalies is presented in Table 4.
Documented type IV ocular anomalies
Type IV ocular anomalies were described
in three records22,31,33. Hertle et al. de-
scribed refractive errors in 27% of
patients, with irregular astigmatism being
the most frequently described anomaly in
18.4–76.9% of patients22,31. Anisometro-
pia was described in 16.3%22. Hyperopia
was described in 4.1%22. Finally, myopia
was described in 4.1–4.8% of patients22,33.
An overview of the type IV ocular anom-
alies is presented in Table 5.
Documented visual acuity
Visual acuity was described in three
papers22,30,36. Visual impairment was de-
scribed in 8–71.4% of patients, of whom
11.1–71.4% were described as having se-
vere visual impairment30,36. The definition
of severe visual impairment was not pro-
vided in these papers. Stro¨mland et al.
reported five of 16 patients with visual
acuity 0.3 LogMAR and two of 16 as
blind30. Amblyopia was described in
16.3% by Hertle et al., indicating a unilat-
eral visual acuity worse than 20/4022.
Margolis et al. described visual acuity
testing in two patients, one patient with
a unilateral visual acuity of 20/200 and
one with a unilateral visual acuity of finger
counting at three feet36.
Discussion
The aim of this systematic review was
to describe the incidence and types of
ocular anomalies in CFM. This systematic
review is novel, particularly in regard
to the attempted classification of the
different ocular and adnexal anomalies.
It should be noted that this is not anacial microsomia: a systematic review, Int
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Table 1. Study characteristics.
Year Author
CEBM level
of evidence
Number of
patients
included Methodology Inclusion criteria of the study
% ocular
anomalies
2014 Barisic et al.18 3 259 Retrospective study Microtia or ear anomaly and one of the
following anomalies: HFM, epibulbar
dermoid, vertebral malformation
24.3%
1973 Baum and
Feingold31
4 13 Case series Unknown/GS 100%
2015 Beleza-Meireles
et al.19
3 51 Retrospective study Facial asymmetry and microtia or ear
malformations
29%
1974 Converse et al.32 4 15 Case series Bilateral CFM 6.7%
1993 Cousley20 3 50 Retrospective study HFM 49% of 53
affected sides (3
patients were
affected
bilaterally)
2015 da Silva et al.21 3 20 Retrospective study Inclusion criteria for CFM by Stro¨mland
et al. (OAVS phenotype with anomalies in
at least 2 of the following:
orocraniofacial, ocular, auricular, and/or
vertebral)
60%
2000 Ewart-Toland
et al.33
4 14 Case series OAVS patients born of diabetic mothers 57%
1978 Feingold and
Baum34
4 16a Case series Eye anomaly (lipodermoid/epibulbar
dermoid/upper eyelid coloboma) and two
of the following: ear/mandible/vertebral
anomaly
100%
1992 Hertle et al.22 3 49 Retrospective study HFM/CFM with complete ocular
examination, GS was excluded
67%
1997 Jacobsson and
Granstro¨m23
3 26 Retrospective study Unilateral HFM with ear anomaly and
malar bone hypoplasia and/or maxillary
and/or mandibular micrognathia
At least 27%
2015 Manara et al.35 4 29 Case series OAVS patients with neuro-imaging
studies
Not possible to
calculate
1985 Mansour et al.24 3 57 Retrospective study Facio-auriculo-vertebral sequence 51%
1984 Margolis et al.36 4 7 Case series GS At least 57%
2010 Martelli et al.37 4 6 Case series GS diagnosed with criteria by Stro¨mland
et al.
66.7%
2002 Nijhawan
et al.38
4 7 Case series GS with caruncle anomalies 100%
2003 Poon et al.25 3 65 Retrospective study HFM/OAVD/facio-auricular-vertebral
dysplasia/GS
23% (anomaly
in OMENS ‘O’)
2001 Rahbar et al.29 3 40 Retrospective study HFM with temporal bone CT scan 12.5% (anomaly
in OMENS ‘O’)
1982 Rao et al.39 4 10 Case series GS 100%
1987 Rollnick et al.26 3 294 Retrospective study Microtia 20%
2010 Rosa et al.40 4 17 Case series OAVS (at least two of the following:
orocraniofacial, ocular, auricular,
vertebral) and radiographic imaging (CT/
MRI) of CNS and normal karyotype
At least 24%
2007 Stro¨mland
et al.30
3 18 Retro- and
prospective study
GS/OAVS/HFM (at least two of the
following: orocraniofacial, ocular,
auricular, vertebral)
72%
2005 Tasse et al.27 3 53 Retrospective study OAVS (minimal diagnostic criteria,
isolated microtia or HFM with mild ear
malformations)
At least 31%
2015 Tuin et al.16 3 138 Retrospective study CFM or GS At least 17%
1991 Vento et al.15 3 154 Retrospective study HFM and/or microtia At least 21%
1979 Whitaker et al.28 3 24 Retrospective study HFM patients who underwent craniofacial
surgery
At least 46%
CEBM, Centre for Evidence-Based Medicine; CFM, craniofacial microsomia; CNS, central nervous system; CT, computed tomography; GS,
Goldenhar syndrome; HFM, hemifacial microsomia; MRI, magnetic resonance imaging; OAVD, oculo-auriculo-vertebral dysplasia; OAVS,
oculo-auriculo-vertebral syndrome.
a Thirteen patients were also analysed by Baum and Feingold31.
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e.empirical classification, but that the clas-
sification is based on multiple focus group
discussions with experts in the field. There
is insufficient data supporting the claims
that certain anatomical anomalies do not
cause visual impairment, as in type I ocu-
lar anomalies, and that certain anatomical
anomalies do cause visual impairment, as
in type II ocular anomalies. For example,
based on the anatomical location and the
extent of the anomaly, a lipodermoid
could theoretically impair vision. Howev-
er, in our experience this rarely occurs.
Further research is needed to investigate
the relationships between anatomical
anomalies and visual impairment.
Most records described type I and type
II ocular anomalies, specifically epibulbar
dermoids, eyelid colobomas, and micro-
phthalmia15,16,18–21,23–27,30–34,36,37,39,40.
Photographs of these anomalies are pre-
sented in Figs 2–4, respectively. It is worth
noting that Baum and Feingold described a
canthus coloboma31, which is an unusual
finding in CFM, as colobomas in CFM
usually involve the upper eyelid and not
the canthus region. Many anomalies were
only described in a few papers and in
general showed relatively small incidence
rates, indicating that these anomalies are
likely easily overlooked.
The wide range of incidences of ocular
anomalies, between 6.7% and 100%, can
be attributed to the difference in patient
selection, aim of the study, and methodol-
ogy. For instance, in a study investigating
GS, the incidence of ocular anomalies
should be 100%, as an epibulbar dermoid
is part of the definition of GS; this was the
case in three studies31,38,39. However, as
stated previously by Tuin et al., the defi-
nition of GS is seldom followed16. It is
also important to note that a recent study
found no phenotypically distinctive
groups in the CFM spectrum, thereby
indicating that there are no grounds to
identify GS as a separate entity within
the CFM spectrum17. Furthermore, the
inclusion and exclusion criteria in the
included papers varied substantially or
were unknown, explaining the different
incidences of ocular anomalies to some
extent. It should be noted that only Hertle
et al.22 excluded patients without a known
ophthalmological examination, as their
aim was to document ocular anomalies
in CFM. None of the other papers
had the sole aim of describing ocular
anomalies. It therefore seems likely that
the incidence of ocular anomalies lies
close to 67%, as described by Hertle
et al.22.
Furthermore, only seven papers
described anomalies that could onlyacial microsomia: a systematic review, Int
6 Rooijers et al.
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Table 3. Percentage of patients with type II ocular anomalies per record.
Author
Included
patients Microphthalmia Anophthalmia
Epibulbar
dermoid
Exposure
keratitis/cornea
ulcer
Opacity
lens
Fundus
coloboma
Optic
nerve
anomalies
Barisic et al.18 259 5.4 1.5 7.7
Baum and Feingold31 13 7.7 69.2 7.7 7.7
Beleza-Meireles et al.19 51 3.9 15.7
Converse et al.32 15 6.7
Cousley20 50 15
da Silva et al.21 20 10 25
Ewart-Toland et al.33 14 9.5 14.3 4.8 4.8
Feingold and Baum34 16 62.5
Jacobsson and Granstro¨m23 26 3.8
Manara et al.35 29 13.8
Mansour et al.24 57 1.8 32 1.8
Margolis et al.36 7 57.1 42.9 14.3
Martelli et al.37 6 50 16.7 33.3
Poon et al.25 65 12
Rao et al.39 10 100 30
Rollnick et al.26 294 * * * *
Rosa et al.40 17 11.8 23.5
Stro¨mland et al.30 18 22.2 44.4
Tasse et al.27 53 3.8
Tuin et al.16 138 14.4 17
Vento et al.15 154 4 20.8
*Not possible to calculate percentage.
Table 4. Percentage of patients with type III ocular anomalies per record.
Author
Included
patients Ptosis
Extraocular
muscle
anomaly
(undefined)
Strabismus
(undefined)
Duane
syndrome Esotropia Exotropia
Abducens
nerve
palsy
Abducens
nerve
anomaly Nystagmus
Baum and Feingold31 13 38.5 15.4 15.4 7.7
da Silva et al.21 20 15
Feingold and Baum34 16 31.3
Hertle et al.22 49 12.2 22 6.1 4.1 6.1 4.1 6.1
Jacobsson and
Granstro¨m23
26 26.9
Manara et al.35 29 27.6
Mansour et al.24 57 12 19 1.8 10.5 5.3
Margolis et al.36 7 14.3 14.3 28.6
Rao et al.39 10 * *
Rollnick et al.26 294 * * * *
Rosa et al.40 17 11.8 5.9
Tasse et al.27 53 7.7
Whitaker et al.28 24 8.3
*Not possible to calculate percentage.
Table 5. Percentage of patients with type IV ocular anomalies per record.
Author
Included
patients
Refractive
errors (undefined)
Irregular
astigmatism Anisometropia Hyperopia Myopia
Baum and Feingold31 13 76.9
Ewart-Toland et al.33 14 4.8
Hertle et al.22 49 27 18.4 16.3 4.1 4.1be seen while performing fundo-
scopy22,24,26,31,33,35,36 and three papers de-
scribed visual acuity22,31,33. This suggests
that most papers did not include informa-
tion about ophthalmological examina-
tions, or that patients simply had notPlease cite this article in press as: Rooijers W
J Oral Maxillofac Surg (2020), https://doi.oundergone an ophthalmological examina-
tion. In light of the data, specifically
the large incidence of (severe) visual im-
pairment and preventable causes of visual
impairment, such as exposure keratitis
in 7.7–30%, we strongly recommend, et al. Ocular and adnexal anomalies in craniof
rg/10.1016/j.ijom.2020.03.003that all CFM patients undergo a full
ophthalmological and orthoptic examina-
tion at least once during the sensitive
period. It is beyond the scope of this
review to discuss the treatment options
and timing of treatment for the ocularacial microsomia: a systematic review, Int
Ocular and adnexal anomalies in CFM 7
YIJOM-4393; No of Pages 8
Fig. 2. Picture showing an epibulbar dermoid in both the right and left eye (arrows).
Fig. 3. Picture showing a normal right eye and anomalies of the left eye: there is an upper eyelid
coloboma (arrow) and dystopia with inferior displacement of the left orbit.
Fig. 4. Picture showing a normal right eye and a microphthalmic left eye.anomalies described. Further research is
needed to develop a specific screening
protocol for CFM patients.
In conclusion, this article provides a
detailed overview of the known ocular
anomalies in CFM patients and their re-
spective incidences. Ocular anomalies
were present in 6.7–100% of patients.
We propose a classification for ocular
anomalies, identifying four different types
of ocular anomalies, to offer a relatively
concise separation of the anomalies and
the impact that they may have on the
patient. Finally, the incidence of visual
impairment was found to range from 8%
to 71.4%, hence we recommend a full
ophthalmological and orthoptic examina-
tion as part of the assessment of CFM
patients.
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